Unichem Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE351A01035
NSEID: UNICHEMLAB
BSEID: 506690
View on NSE | View on BSE

INR

405.10

6.05 (1.52%)

BSENSE

Feb 09

BSE+NSE Vol: 10.49 k

{
  "main_header": {
    "sid": 270205,
    "name": "Unichem Labs.",
    "stock_name": "Unichem Labs.",
    "full_name": "Unichem Laboratories Ltd",
    "name_url": "stocks-analysis/unichem-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "405.10",
    "chg": 6.05,
    "chgp": "1.52%",
    "dir": 1,
    "prev_price": "399.05",
    "mcapval": "2,852.14 Cr",
    "mcap": "Small Cap",
    "scripcode": 506690,
    "symbol": "UNICHEMLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE351A01035",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "10.49 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/unichem-labs-270205-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Unichem Laboratories Downgraded to Strong Sell Amid Financial and Operational Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unichem-laboratories-downgraded-to-strong-sell-amid-financial-and-operational-challenges-3828013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_mojoScore_3828013.png",
        "date": "2026-02-09 08:11:02",
        "description": "Unichem Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 6 February 2026, reflecting deteriorating financial trends, valuation shifts, and technical weaknesses. Despite some operational strengths, the company’s recent quarterly results and long-term performance metrics have raised concerns among analysts, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Unichem Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-ltd-valuation-shifts-signal-changing-market-sentiment-3827756",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_valuationdot_3827756.png",
        "date": "2026-02-09 08:00:36",
        "description": "Unichem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a recent sharp decline in share price. This change reflects evolving market perceptions amid challenging financial metrics and sector-wide valuation trends, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks."
      },
      {
        "title": "Unichem Laboratories Gains 6.58%: 4 Key Factors Driving This Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-gains-658-4-key-factors-driving-this-weeks-volatility-3827374",
        "imagepath": "",
        "date": "2026-02-08 11:00:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Modest opening gain amid weak Sensex</p>\n                    <p><strong>3 Feb:</strong> Intraday high surge of 7.29%, stock hits Rs.408</p>\n                    <p><strong>5 Feb:</strong> Q3 FY26 results reveal margin pressure despite EPS peak</p>\n                    <p><strong>6 Feb:</strong> Sharp intraday low and 7.21% decline amid price pressure</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.374.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.399.05</div><div..."
      },
      {
        "title": "Unichem Laboratories Ltd Hits Intraday Low Amid Price Pressure on 6 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-6-feb-2026-3824237",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_priceRelatedfactors_3824237.png",
        "date": "2026-02-06 10:31:45",
        "description": "Shares of Unichem Laboratories Ltd declined sharply on 6 Feb 2026, hitting an intraday low of Rs 400.65, reflecting significant price pressure as the stock underperformed its sector and broader market indices."
      },
      {
        "title": "Unichem Laboratories Reports Negative Financial Trend Amidst Margin Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-reports-negative-financial-trend-amidst-margin-pressure-3823465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_fintrenddot_3823465.png",
        "date": "2026-02-06 08:00:07",
        "description": "Unichem Laboratories Ltd has reported a marked deterioration in its financial performance for the quarter ended December 2025, with key metrics signalling a shift from a previously flat trend to a negative trajectory. Despite some operational strengths, the pharmaceutical company faces significant challenges in profitability and margin sustainability, prompting a downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Are Unichem Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-unichem-laboratories-ltd-latest-results-good-or-bad-3822882",
        "imagepath": "",
        "date": "2026-02-05 19:23:21",
        "description": "Unichem Laboratories Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported a net profit of ₹264.29 crores, which reflects a significant year-on-year increase, primarily driven by exceptional gains. However, this profit surge masks underlying operational challenges, as the company's revenue declined by 2.24% year-on-year to ₹521.17 crores, marking the lowest quarterly sales of the fiscal year. Sequentially, revenue also fell by 9.98% from the previous quarter, indicating a concerning trend in sales performance.\n\nThe operating margin, excluding other income, compressed significantly to 8.59%, down from 16.04% in the same quarter last year. This decline of 746 basis points highlights persistent pressure on the company's core business operations. Additionally, the profit before tax of ₹293.43 crores indicates that a substantial portion of this figure is attributable to excep..."
      },
      {
        "title": "Unichem Laboratories Q3 FY26: Exceptional Gain Masks Operational Struggles",
        "link": "https://www.marketsmojo.com/news/result-analysis/unichem-laboratories-q3-fy26-exceptional-gain-masks-operational-struggles-3822796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_quaterlyResult_3822796.png",
        "date": "2026-02-05 17:45:46",
        "description": "Unichem Laboratories Ltd., the Mumbai-based pharmaceutical manufacturer with a market capitalisation of ₹2,926 crores, reported a staggering net profit of ₹264.29 crores for Q3 FY26 (October-December 2025), representing an extraordinary 356.85% year-on-year surge. However, this headline-grabbing figure conceals a troubling operational reality: the company's core business continues to struggle with declining margins and shrinking profitability, whilst the reported profit stems primarily from a one-time exceptional gain rather than sustainable business performance."
      },
      {
        "title": "Unichem Laboratories Ltd Hits Intraday High with 7.29% Surge on 3 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unichem-laboratories-ltd-hits-intraday-high-with-729-surge-on-3-feb-2026-3818417",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_priceRelatedfactors_3818417.png",
        "date": "2026-02-03 11:06:35",
        "description": "Unichem Laboratories Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.29% to touch a day’s high of Rs 408, significantly outperforming the Pharmaceuticals & Biotechnology sector and broader market indices."
      },
      {
        "title": "Unichem Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unichem-laboratories-ltd-is-rated-sell-3814195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnichemLaborato_mojoScore_3814195.png",
        "date": "2026-02-01 10:10:04",
        "description": "Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 553,
    "sid": "270205",
    "stock_news_url": "https://www.marketsmojo.com/news/unichem-laboratories-270205"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "06-Feb-2026",
      "details": "Disclosure u/r. 30 0f SEBI Listing Regulations",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Feb-2026",
      "details": "Financial Results for the quarter and nine months ended December 31 2025 published in the newspaper on February 6 2026.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results",
      "datetime": "05-Feb-2026",
      "details": "Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Unichem Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 01 Aug 22",
          "dt": "2022-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Unichem Laboratories Ltd has announced <strong>2:5</strong> stock split, ex-date: 21 Oct 10",
          "dt": "2010-10-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Unichem Laboratories Downgraded to Strong Sell Amid Financial and Operational Challenges

2026-02-09 08:11:02

Unichem Laboratories Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 6 February 2026, reflecting deteriorating financial trends, valuation shifts, and technical weaknesses. Despite some operational strengths, the company’s recent quarterly results and long-term performance metrics have raised concerns among analysts, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

Unichem Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment

2026-02-09 08:00:36

Unichem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a recent sharp decline in share price. This change reflects evolving market perceptions amid challenging financial metrics and sector-wide valuation trends, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.

Read full news article

Unichem Laboratories Gains 6.58%: 4 Key Factors Driving This Week’s Volatility

2026-02-08 11:00:12

Key Events This Week

2 Feb: Modest opening gain amid weak Sensex

3 Feb: Intraday high surge of 7.29%, stock hits Rs.408

5 Feb: Q3 FY26 results reveal margin pressure despite EPS peak

6 Feb: Sharp intraday low and 7.21% decline amid price pressure

Read full news article

Unichem Laboratories Ltd Hits Intraday Low Amid Price Pressure on 6 Feb 2026

2026-02-06 10:31:45

Shares of Unichem Laboratories Ltd declined sharply on 6 Feb 2026, hitting an intraday low of Rs 400.65, reflecting significant price pressure as the stock underperformed its sector and broader market indices.

Read full news article

Unichem Laboratories Reports Negative Financial Trend Amidst Margin Pressure

2026-02-06 08:00:07

Unichem Laboratories Ltd has reported a marked deterioration in its financial performance for the quarter ended December 2025, with key metrics signalling a shift from a previously flat trend to a negative trajectory. Despite some operational strengths, the pharmaceutical company faces significant challenges in profitability and margin sustainability, prompting a downgrade in its Mojo Grade to Sell.

Read full news article

Are Unichem Laboratories Ltd latest results good or bad?

2026-02-05 19:23:21

Unichem Laboratories Ltd's latest financial results for Q3 FY26 present a complex picture. The company reported a net profit of ₹264.29 crores, which reflects a significant year-on-year increase, primarily driven by exceptional gains. However, this profit surge masks underlying operational challenges, as the company's revenue declined by 2.24% year-on-year to ₹521.17 crores, marking the lowest quarterly sales of the fiscal year. Sequentially, revenue also fell by 9.98% from the previous quarter, indicating a concerning trend in sales performance. The operating margin, excluding other income, compressed significantly to 8.59%, down from 16.04% in the same quarter last year. This decline of 746 basis points highlights persistent pressure on the company's core business operations. Additionally, the profit before tax of ₹293.43 crores indicates that a substantial portion of this figure is attributable to excep...

Read full news article

Unichem Laboratories Q3 FY26: Exceptional Gain Masks Operational Struggles

2026-02-05 17:45:46

Unichem Laboratories Ltd., the Mumbai-based pharmaceutical manufacturer with a market capitalisation of ₹2,926 crores, reported a staggering net profit of ₹264.29 crores for Q3 FY26 (October-December 2025), representing an extraordinary 356.85% year-on-year surge. However, this headline-grabbing figure conceals a troubling operational reality: the company's core business continues to struggle with declining margins and shrinking profitability, whilst the reported profit stems primarily from a one-time exceptional gain rather than sustainable business performance.

Read full news article

Unichem Laboratories Ltd Hits Intraday High with 7.29% Surge on 3 Feb 2026

2026-02-03 11:06:35

Unichem Laboratories Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.29% to touch a day’s high of Rs 408, significantly outperforming the Pharmaceuticals & Biotechnology sector and broader market indices.

Read full news article

Unichem Laboratories Ltd is Rated Sell

2026-02-01 10:10:04

Unichem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.